Engineering transgenic silkworms to produce spider silk fibers
Engineering transgenic silkworms to produce spider silk fibers
批准号:
7492091
负责人:
Donald L. Jarvis
金额:
$17.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2010-08-31
关键词:
AdoptedAreaBandageBiochemical GeneticsBombyxBurn injuryConditionCosmetic surgeryElasticityEngineeringEnsureFiberFibroinsFutureGenesGenetic TransformationGlandHuman ResourcesIndividualInsectaKnowledgeLigamentsLightMeasuresMechanicsMothsNatureNeurologicOrganPatientsPeptide Leader SequencesPeptidesProductionPropertyProteinsPurposeRecombinant ProteinsRecombinantsRecording of previous eventsResearchResearch PersonnelSilkSkin graftSpidersStagingSurgical suturesSynthetic GenesSystemTendon structureTensile StrengthTimeTransgenic AnimalsTransgenic Organismsbasedesignexperiencemembermutantphysical propertyprogramspromoterprotein structure functionscaffoldsuccesstissue regenerationvector
中文摘要
描述(由申请人提供):丝绸纤维有许多当前和未来的生物医学应用。它们被广泛用作精细的缝合材料,甚至更细的纤维也需要用于眼部、神经系统和美容手术。丝绸纤维也有希望作为人造韧带和肌腱的材料,它们还有许多其他潜在的生物医学应用。许多不同的重组蛋白生产系统已经被用来试图满足当前的需求,并开发更多的生物医学应用的丝绸。每一种都产生了丝蛋白,但没有一种一直产生有用的丝纤维。因此,本R21探索性提案的总体目的是开发一种可以生产蜘蛛丝纤维的系统。我们的基本方法是采用蚕作为蜘蛛丝蛋白生产的替代宿主。这种高效的“背驮式”系统将被用于对不产天然丝的突变蚕进行基因改造,用一种合成基因编码一种异常大的蜘蛛丝蛋白。由此产生的转基因蚕的遗传和生化特性,特别是它们生产蜘蛛丝纤维的能力,将被严格评估。我们计划的一个关键特点是,它包括了一些具体的措施,这些措施将优化我们获得纤维的能力。这些方法包括:(i)使用合成基因编码异常大的蜘蛛丝蛋白,(ii)使用启动子靶向异源丝蛋白在丝腺中的表达,丝腺天生具备纺丝纤维的能力,(iii)使用合适的先导肽从丝腺分泌,(iv)使用替代宿主,蚕蛾,它高度适应遗传转化,天生具备纺丝纤维的能力。在这个探索性项目中,成功分离出一种可以生产蜘蛛丝纤维的转基因蚕蛾,将为未来的项目奠定基础,这些项目旨在进一步开发该系统,以生产具有预先确定的物理特性的蜘蛛丝纤维,并针对特定的生物医学应用进行优化。这将利用目前对蜘蛛丝的抗拉强度或弹性有贡献的特定肽基序的知识。从理论上讲,这些图案可以以各种方式组合在一起,设计出不同强度和弹性的丝绸纤维。当前项目成功完成的总体可能性提高了,因为它将由一个由三名研究人员组成的团队进行,并在项目的三个关键领域建立了互补的项目:蜘蛛丝(Lewis)、昆虫表达系统(Jarvis)和昆虫转化(Fraser)。丝绸纤维在当前和未来的生物医学上有许多应用。它们被广泛用作精细的缝合材料,甚至更细的纤维也需要用于眼部、神经系统和美容手术。丝绸纤维也有希望作为人造韧带和肌腱的材料,它们还有许多其他潜在的生物医学应用。许多不同的重组蛋白生产系统已经被用来试图满足当前的需求,并开发更多的生物医学应用的丝绸。每一种都产生了丝蛋白,但没有一种一直产生有用的丝纤维。因此,R21探索性提案的总体目的是开发一种可以为这些当前和未来的生物医学应用生产蜘蛛丝纤维的系统。我们对这个探索性项目的计划是分离一种可以生产蜘蛛丝纤维的转基因蚕。如果这个项目成功,它将为未来的项目奠定基础,旨在进一步开发该系统,生产具有预先确定的物理特性的蜘蛛丝纤维,以优化特定的生物医学应用。这些项目将利用目前对蜘蛛丝的抗拉强度或弹性有贡献的特定肽基序的知识。
英文摘要
DESCRIPTION (provided by applicant): Silk fibers have many current and future biomedical applications. They are widely used as fine suture materials and even thinner fibers are needed for ocular, neurological, and cosmetic surgeries. Silk fibers also hold promise as materials for artificial ligaments and tendons and they have many other potential biomedical applications. Many different recombinant protein production systems have been used to try to meet current needs and to develop additional biomedical applications of silks. Each has yielded silk proteins, but none has consistently yielded useful silk fibers. Thus, the overall purpose of this R21 exploratory proposal is to develop a system that can produce spider silk fibers. Our basic approach will be to adopt the silkworm as a surrogate host for spider silk protein production. The highly efficient piggybac system will be used to genetically transform mutant silkworms, which produce no native silk, with a synthetic gene encoding an unusually large spider silk protein. The genetic and biochemical properties of the resulting transgenic silkworms, particularly their ability to produce spider silk fibers, will then be critically assessed. A key feature of our plan is that it includes specific measures that will optimize our ability to obtain fibers. These include: (i) using a synthetic gene encoding an unusually large spider silk protein, (ii) using a promoter that targets expression of the heterologous silk proteins to the silk gland, which is naturally equipped to spin silk fibers, and (iii) using an appropriate leader peptide for secretion from the silk gland, and (iv) using a surrogate host, the silk moth, which is highly amenable to genetic transformation and naturally equipped to spin silk fibers. The successful isolation of a transgenic silkmoth that can produce spider silk fibers in this exploratory project will set the stage for future projects designed to further develop this system to produce spider silk fibers with pre-determined physical properties optimized for specific biomedical applications. This will exploit current knowledge of specific peptide motifs contributing tensile strength or elasticity to spider silks. Theoretically, these motifs can be combined in various ways to design silk fibers differing in strength and elasticity. The overall likelihood that the current project can be successfully completed is enhanced by the fact that it will be undertaken by a team of three researchers with established, complementary programs in three areas key to the project: spider silks (Lewis), insect expression systems (Jarvis), and insect transformation (Fraser). Silk fibers have many current and future biomedical applications. They are widely used as fine suture materials and even thinner fibers are needed for ocular, neurological, and cosmetic surgeries. Silk fibers also hold promise as materials for artificial ligaments and tendons and they have many other potential biomedical applications. Many different recombinant protein production systems have been used to try to meet current needs and to develop additional biomedical applications of silks. Each has yielded silk proteins, but none has consistently yielded useful silk fibers. Thus, the overall purpose of this R21 exploratory proposal is to develop a system that can produce spider silk fibers for these current and future biomedical applications. Our plan for this exploratory project is to isolate a transgenic silkworm that can produce spider silk fibers. If this project is successful, it will set the stage for future projects designed to further develop this system to produce spider silk fibers with pre-determined physical properties optimized for specific biomedical applications. These projects will exploit current knowledge of specific peptide motifs contributing tensile strength or elasticity to spider silks.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Impact of Fc N-glycan structure on HIV-specific antibody functions
-
批准号:9322012
-
项目类别:
-
资助金额:$74.83万
-
财政年份:2016
-
负责人:Donald L. Jarvis
-
依托单位:
Elucidating the cellular mechanisms of prion propagation and clearance for devisi
-
批准号:8663969
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2012
-
负责人:Donald L. Jarvis
-
依托单位:
Elucidating the cellular mechanisms of prion propagation and clearance for devisi
-
批准号:9070005
-
项目类别:
-
资助金额:$30.95万
-
财政年份:2012
-
负责人:Donald L. Jarvis
-
依托单位:
Elucidating the cellular mechanisms of prion propagation and clearance for devisi
-
批准号:8847411
-
项目类别:
-
资助金额:$30.95万
-
财政年份:2012
-
负责人:Donald L. Jarvis
-
依托单位:
Elucidating the cellular mechanisms of prion propagation and clearance for devisi
-
批准号:8465922
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2012
-
负责人:Donald L. Jarvis
-
依托单位:
N-glycosylation mechanism in insect cells
-
批准号:7850002
-
项目类别:
-
资助金额:$27.31万
-
财政年份:2009
-
负责人:Donald L. Jarvis
-
依托单位:
Engineering transgenic silkworms to produce spider silk fibers
-
批准号:7364972
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2007
-
负责人:Donald L. Jarvis
-
依托单位:
A novel transgenic silkworm system for recombinant glycoprotein production
-
批准号:7908796
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2007
-
负责人:Donald L. Jarvis
-
依托单位:
A novel transgenic silkworm system for recombinant glycoprotein production
-
批准号:7368649
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2007
-
负责人:Donald L. Jarvis
-
依托单位:
A novel transgenic silkworm system for recombinant glycoprotein production
-
批准号:7666717
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2007
-
负责人:Donald L. Jarvis
-
依托单位:
A novel transgenic silkworm system for recombinant glycoprotein production
-
批准号:7501936
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2007
-
负责人:Donald L. Jarvis
-
依托单位:
N-GLYCOSYLATION MECHANISM IN INSECT CELLS
-
批准号:2695957
-
项目类别:
-
资助金额:$20.4万
-
财政年份:1994
-
负责人:Donald L. Jarvis
-
依托单位:
N-glycosylation mechanism in insect cells.
-
批准号:6541361
-
项目类别:
-
资助金额:$25.9万
-
财政年份:1994
-
负责人:Donald L. Jarvis
-
依托单位:
N-glycosylation mechanism in insect cells
-
批准号:7321419
-
项目类别:
-
资助金额:$27.17万
-
财政年份:1994
-
负责人:Donald L. Jarvis
-
依托单位:
N-glycosylation mechanism in insect cells
-
批准号:7469430
-
项目类别:
-
资助金额:$27.17万
-
财政年份:1994
-
负责人:Donald L. Jarvis
-
依托单位:
N-glycosylation mechanism in insect cells.
-
批准号:6929722
-
项目类别:
-
资助金额:$23.35万
-
财政年份:1994
-
负责人:Donald L. Jarvis
-
依托单位:
N-glycosylation mechanism in insect cells
-
批准号:7631374
-
项目类别:
-
资助金额:$27.17万
-
财政年份:1994
-
负责人:Donald L. Jarvis
-
依托单位:
N-glycosylation mechanism in insect cells.
-
批准号:6640039
-
项目类别:
-
资助金额:$24.59万
-
财政年份:1994
-
负责人:Donald L. Jarvis
-
依托单位:
N-GLYCOSYLATION MECHANISM IN INSECT CELLS
-
批准号:2187266
-
项目类别:
-
资助金额:$14.68万
-
财政年份:1994
-
负责人:Donald L. Jarvis
-
依托单位:
N-GLYCOSYLATION MECHANISM IN INSECT CELLS
-
批准号:6018961
-
项目类别:
-
资助金额:$18.0万
-
财政年份:1994
-
负责人:Donald L. Jarvis
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: